Company Profile
Prodia was first established in Solo on 7 May 1973. Prodia’s commitment to providing the best test results ultimately led Prodia to become the best and largest Clinical Laboratory in Indonesia.
More
Subsidiary and Associated Entities
Prodia has subsidiary and associated entities that strengthen its healthcare ecosystem. PT Prodia Digital Indonesia (PRDI) focuses on digital health solutions through U by Prodia, enabling users to monitor and manage their health with ease. PT Prodia Diagnostic Line (Proline) provides comprehensive In Vitro Diagnostics (IVD) solutions with high local content (TKDN) products listed in the national e-catalog. Meanwhile, PT Prodia StemCell Indonesia (ProSTEM), a pioneer in stem cell therapy since 2010 certified with ISO 9001:2015 and GMP, continues to drive innovation in regenerative medicine through clinical trials and global collaborations.
Investor Relations
On 7 December 2016, the Indonesia Stock Exchange (IDX) officially listed the initial public offering of Prodia as the 15th issuer in 2016 under the ticker symbol “PRDA.”
More
Corporate Governance
Prodia consistently implements best corporate governance practices per the best practices standards and applicable regulations.
More
Sustainability
Prodia is committed to improving public health quality through consistent and sustainable Corporate Social Responsibility (CSR) activities.
More
Career
Prodia is committed to developing a highly competent workforce with the agility and digital mindset to continue growing and adhering to The Spirit of Prodia amid dynamic industrial developments.
MoreLocation
Prodia has a network of health services spread across 34 provinces throughout Indonesia.
Contact Us
Kontak Prodia serves customers needing the latest information about Prodia. Customers may also submit complaints, suggestions, and inputs for Prodia through Kontak Prodia.